TPOXX® Antiviral Treatment (Tecovirimat)
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · Awarded
- Buyer
- Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
- Status
- Awarded
- Country
- United Kingdom
- Region
- England
- Sector
- Manufacturing
- Reference
- FaT-ocds-h6vhtk-037efd
- Published
- 2022-11-03
- Deadline
- 2026-04-25
Tender summary
The monkeypox virus belongs to a family of viruses called orthopox viruses and the drug Tecovirimat is an antiviral designed specifically to treat viral infections of this kind. In the current outbreak, Tecovirimat has been successfully used to treat patients with the most severe presentations of monkeypox virus infection. This contract is for a small supply of TPOXX® Antiviral Treatment (Tecovirimat) for the treatment of severe cases of Monkeypox in the UK.
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access